What is the concern about Singulair (montelukast)?
Singulair is a major drug in asthma treatment – it is important to review recent developments and put these findings in perspective of overall asthma care for individual patients.
Singulair (manufactured and marketed by Merck and Co.) is a drug of the so-called anti-leukotriene class that is used for control of symptoms of asthma and allergic rhinitis (hay fever). It was initially approved by the U.S. Food and Drug...
These are adult asthmatics who sometimes have mild asthma symptoms, and when they do they take a puff or two or three or four of their quick-relief... Read more »
These are the asthmatics who, regardless of how compliant they are with their preventative medicines, still have bad asthma episodes. We don't know... Read more »